Patient- and Technician-Oriented Attitudes Toward Transcranial Magnetic Stimulation Devices
Technician
Tolerability
Brain stimulation
Depression
DOI:
10.1176/appi.neuropsych.17070146
Publication Date:
2018-01-25T08:01:05Z
AUTHORS (8)
ABSTRACT
Four transcranial magnetic stimulation (TMS) devices are currently approved for use in treatment-resistant depression. The authors present the first data-driven study examining patient- and technician-experience using three of these distinct devices. A retrospective survey design with both patient technician arms was utilized. population included patients who received TMS depression at Berenson Allen Center Noninvasive Brain Stimulation time between 2013 2016 technicians worked program from 2009 to 2017. Statistical analysis t tests analyses variance assess differences across multiple groups, respectively. Patients treated NeuroStar device reported greater confidence that treatment being performed correctly compared those Magstim device. Conversely, regard tolerability, less pain last week on average On average, feeling were significantly easier than Brainsway Deep H-Coil Additionally, they found former two be more reliable better tolerated. Furthermore, indicated would likely recommend other centers.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (3)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....